Manfred Dietel combines Cancer and Breast cancer in his studies. Breast cancer and Cancer research are two areas of study in which he engages in interdisciplinary research. His study deals with a combination of Cancer research and Chemotherapy. Manfred Dietel merges Chemotherapy with Cancer in his study. Internal medicine is frequently linked to Immunohistochemistry in his study. He integrates many fields in his works, including Immunohistochemistry and Tissue microarray. Manfred Dietel regularly links together related areas like Internal medicine in his Tissue microarray studies. His study on Pathology is mostly dedicated to connecting different topics, such as Carcinoma. His study brings together the fields of Pathology and Carcinoma.
Manfred Dietel incorporates Cancer and Breast cancer in his studies. Manfred Dietel integrates Breast cancer and Cancer in his research. He combines topics linked to Ovarian cancer with his work on Internal medicine. His study in Internal medicine extends to Ovarian cancer with its themes. Manfred Dietel combines Pathology and Immunohistochemistry in his research. His multidisciplinary approach integrates Immunohistochemistry and Pathology in his work. Manfred Dietel brings together Cancer research and Oncology to produce work in his papers. Manfred Dietel brings together Oncology and Cancer research to produce work in his papers. Manfred Dietel undertakes interdisciplinary study in the fields of Genetics and Molecular biology through his research.
His study brings together the fields of Concordance and Internal medicine. His Concordance study frequently draws connections between adjacent fields such as Internal medicine. In his research, he undertakes multidisciplinary study on Cancer and Colorectal cancer. Manfred Dietel combines topics linked to Serous fluid with his work on Pathology. His work on Pathology expands to the thematically related Serous fluid. His work blends Oncology and Cancer research studies together. He performs integrative Cancer research and Oncology research in his work. He merges Gene with Immunohistochemistry in his research. His work often combines Immunohistochemistry and Gene studies.
The study of Serous carcinoma and Ovarian carcinoma are components of his Ovarian cancer research. Much of his study explores Ovarian carcinoma relationship to Ovarian cancer. His Internal medicine study frequently draws connections to adjacent fields such as Serous carcinoma. In his research, Manfred Dietel performs multidisciplinary study on Cancer and Medical physics. In his papers, Manfred Dietel integrates diverse fields, such as Medical physics and Cancer. His Malignant pleural effusion research extends to the thematically linked field of Oncology. Malignant pleural effusion and Anaplastic lymphoma kinase are frequently intertwined in his study. His Anaplastic lymphoma kinase study frequently draws connections to other fields, such as Oncology. His Clinical trial research extends to the thematically linked field of Pathology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2–Positive and Triple-Negative Primary Breast Cancers
Carsten Denkert;Gunter von Minckwitz;Jan C. Brase;Bruno V. Sinn.
Journal of Clinical Oncology (2015)
A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal.
Guido Rindi;David S. Klimstra;Behnoush Abedi-Ardekani;Sylvia L. Asa.
Modern Pathology (2018)
HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing
Josef Rüschoff;Manfred Dietel;Gustavo B Baretton;Susanne Arbogast.
Virchows Archiv (2010)
Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy
W Weichert;A Röske;V Gekeler;T Beckers.
British Journal of Cancer (2008)
Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines.
Douglas D. Ross;Weidong Yang;Lynne V. Abruzzo;William S. Dalton.
Journal of the National Cancer Institute (1999)
Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors.
Carsten Denkert;Jan Budczies;Tobias Kind;Wilko Weichert.
Cancer Research (2006)
Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis
Wilko Weichert;Annika Röske;Volker Gekeler;Thomas Beckers.
Lancet Oncology (2008)
Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas.
Olaf Kaufmann;Ellen Fietze;Jörg Mengs;Manfred Dietel.
American Journal of Clinical Pathology (2001)
Expression of thyroid transcription factor-1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites.
O Kaufmann;M Dietel.
Metabolite profiling of human colon carcinoma--deregulation of TCA cycle and amino acid turnover.
Carsten Denkert;Jan Budczies;Wilko Weichert;Gert Wohlgemuth.
Molecular Cancer (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: